Disposition of 3290 shares by James Polewaczyk of IDEXX Laboratories at 558.8822 subject to Rule 16b-3

IX1 Stock  EUR 420.70  3.50  0.83%   
Roughly 61% of IDEXX Laboratories' investor base is looking to short. The analysis of current outlook of investing in IDEXX Laboratories suggests that many traders are alarmed regarding IDEXX Laboratories' prospects. The current market sentiment, together with IDEXX Laboratories' historical and current headlines, can help investors time the market. In addition, many technical investors use IDEXX Laboratories stock news signals to limit their universe of possible portfolio assets.
IDEXX Laboratories stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of IDEXX daily returns and investor perception about the current price of IDEXX Laboratories as well as its diversification or hedging effects on your existing portfolios.
  
Filed transaction by IDEXX Laboratories Officer Executive Vice President. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Disposition of 3290 common stock at 558.8822 of IDEXX Laboratories by James Polewaczyk on 24th of August 2024. This event was filed by IDEXX Laboratories with SEC on 2024-03-06. Statement of changes in beneficial ownership - SEC Form 4

IDEXX Laboratories Fundamental Analysis

We analyze IDEXX Laboratories' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IDEXX Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IDEXX Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Income

Net Income Comparative Analysis

IDEXX Laboratories is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

IDEXX Laboratories Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IDEXX Laboratories stock to make a market-neutral strategy. Peer analysis of IDEXX Laboratories could also be used in its relative valuation, which is a method of valuing IDEXX Laboratories by comparing valuation metrics with similar companies.

Complementary Tools for IDEXX Stock analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
CEOs Directory
Screen CEOs from public companies around the world